Presentation on US Hospital Websites of Risks and Benefits of Transcatheter Aortic Valve Replacement Procedures | Valvular Heart Disease | JAMA Internal Medicine | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 18.204.227.34. Please contact the publisher to request reinstatement.
1.
Stacey  D, Légaré  F, Col  NF,  et al.  Decision aids for people facing health treatment or screening decisions.  Cochrane Database Syst Rev. 2014;1:CD001431.PubMedGoogle Scholar
2.
Leon  MB, Smith  CR, Mack  M,  et al; PARTNER Trial Investigators.  Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery.  N Engl J Med. 2010;363(17):1597-1607.PubMedGoogle ScholarCrossref
3.
Reynolds  MR, Magnuson  EA, Wang  K,  et al; PARTNER Trial Investigators.  Health-related quality of life after transcatheter or surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results from the PARTNER (Placement of AoRTic TraNscathetER Valve) Trial (Cohort A).  J Am Coll Cardiol. 2012;60(6):548-558.PubMedGoogle ScholarCrossref
4.
Anderson  JG.  Consumers of e-health: patterns of use and barriers.  Soc Sci Comput Rev. 2004;22(2):242-248. doi:10.1177/0894439303262671.Google ScholarCrossref
5.
Society of Thoracic Surgeons and the American College of Cardiology.  Society of Thoracic Surgeons and American College of Cardiology Transcatheter Valve Therapy Registry (TVT).http://www.ncdr.com/tvt. Accessed May 30, 2014.
Research Letter
March 2015

Presentation on US Hospital Websites of Risks and Benefits of Transcatheter Aortic Valve Replacement Procedures

Author Affiliations
  • 1Tufts University School of Medicine, Boston, Massachusetts
  • 2Department of Anesthesiology and Critical Care, Perelman School of Medicine of the University of Pennsylvania, Philadelphia
  • 3Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia
JAMA Intern Med. 2015;175(3):440-441. doi:10.1001/jamainternmed.2014.7392

Adequate presentation of risks and benefits of medical therapies is essential to informed decision making by patients.1 Transcatheter aortic valve replacement (TAVR) has been recently approved by the US Food and Drug Administration for the treatment of severe aortic stenosis among carefully selected patients; recent randomized clinical trials have identified important positive and negative outcomes of TAVR in these populations, including twice the risk of stroke for patients undergoing TAVR vs those undergoing open aortic valve replacement.2,3 Since 78% of all adults in the United States seek out health information online,4 we assessed the information regarding known risks and benefits of TAVR made available to the public on the websites of US hospitals currently performing TAVR procedures.

×